Actively Recruiting
A Registry Study on HIV-related Lymphoma
Led by Rotkreuzklinikum München gGmbH · Updated on 2023-04-06
300
Participants Needed
6
Research Sites
418 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.
CONDITIONS
Official Title
A Registry Study on HIV-related Lymphoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histology or cytology proven non-Hodgkin lymphoma or Hodgkin lymphoma
- HIV infection at time of lymphoma diagnosis
- Lymphoma diagnosis since 01.01.2010
- Adult patients 18 years or older
- Written informed consent
You will not qualify if you...
- HIV diagnosis more than 3 months after the diagnosis of malignant lymphoma
- Non-compliance or lack of opportunity for follow-up (for the prospective part of the study)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Red Cross Hospital Munich
Munich, Select One Option, Germany, 80634
Actively Recruiting
2
University Hospital Cologne
Cologne, Germany, 50937
Actively Recruiting
3
Amsterdam University Medical Centers
Amsterdam, Netherlands
Not Yet Recruiting
4
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Actively Recruiting
5
Hospital Universitario de Salamanca
Salamanca, Spain
Actively Recruiting
6
University Hospital of Wales
Cardiff, United Kingdom
Not Yet Recruiting
Research Team
M
Marcus Hentrich, MD
CONTACT
K
Kai Hübel, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here